Furthermore, the EMT changes were transient; by day five following treatment the regrowing tumor appeared to be undergoing a mesenchymal to epithelial transition (MET) in the process of reverting to epithelial morphology as judged by the nodule arrangement, E-cadherin association with the adherens junctions and the ZEB1 downregulation. The gene discussed is CDH1; the disease is neoplasm.